Premature babies, born before the 37th week of pregnancy, do not have fully developed lungs and this leads to changes in lung development and breathing problems that may persist long into adulthood. Can.
Researchers at Oregon Health & Science University in the US found that extending CPAP treatment by two weeks could help increase "lung volume and lung expansion capacity".
While the treatment is commonly used for premature infants suffering from breathing problems, the team noted that "there is no consensus on the optimal length of treatment while the premature infant is recovering." Not there".
"Extending CPAP treatment may be a simple and safe approach to improving the lung function and breathing of the preterm infant in the absence of lung development therapy," said Cindy T. McEvoy, MD, professor of pediatrics at the University of Oregon.
"The study findings support CPAP treatment as beneficial for premature infants without the need for pharmaceuticals," he said.
For the study, the team kept a group of premature infants on CPAP treatment for an additional two weeks. After six months, preemies who received the additional treatment had larger, healthier lungs than those who did not.
The findings, which will be presented at the ongoing Pediatric Academic Societies (PAS 2024 meeting) in Toronto, may help physicians determine the appropriate length of treatment.
Researchers at Oregon Health & Science University in the US found that extending CPAP treatment by two weeks could help increase "lung volume and lung expansion capacity".
While the treatment is commonly used for premature infants suffering from breathing problems, the team noted that "there is no consensus on the optimal length of treatment while the premature infant is recovering." Not there".
"Extending CPAP treatment may be a simple and safe approach to improving the lung function and breathing of the preterm infant in the absence of lung development therapy," said Cindy T. McEvoy, MD, professor of pediatrics at the University of Oregon.
"The study findings support CPAP treatment as beneficial for premature infants without the need for pharmaceuticals," he said.
For the study, the team kept a group of premature infants on CPAP treatment for an additional two weeks. After six months, preemies who received the additional treatment had larger, healthier lungs than those who did not.
The findings, which will be presented at the ongoing Pediatric Academic Societies (PAS 2024 meeting) in Toronto, may help physicians determine the appropriate length of treatment.
